{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Navi Mumbai",
      "state": "N/A",
      "country": "India",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "99312",
      "recalling_firm": "Reliance Life Sciences Private Limited",
      "address_1": "Ttc Area Of Midc",
      "address_2": "R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0673-2026",
      "product_description": "Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01",
      "product_quantity": "11,400 vials",
      "reason_for_recall": "Lack of Sterility Assurance",
      "recall_initiation_date": "20260624",
      "center_classification_date": "20260708",
      "report_date": "20260715",
      "code_info": "Lot, expiry:     RBIH0125A Jan 31, 2028; RBIH0225A Feb 29, 2028; RBIH0325A Feb 29, 2028; RBIH0525A Mar 31, 2028"
    }
  ]
}